BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 2, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 1997

View Archived Issues

In vivo profile of AMD-473

Read More

Avigen's gene therapy approach shows promise in preclinical studies

Read More

Gilead Sciences initiates phase I/II trial of oral PMPA for HIV treatment

Read More

In vivo and in vitro characterization of the novel vinca alkaloid F-12158

Read More

Endothelin antagonists described by Takeda

Read More

New antimigraine agents from Merck Sharp & Dohme

Read More

Fibrinogen antagonists reported by Lilly/Cor Therapeutics

Read More

Selective alpha1b-adrenoceptor blockers from Merck & Co.

Read More

GH secretagogues disclosed by Merck & Co.

Read More

Clinical results for titanocene dichloride in solid tumors

Read More

Immunex reports new chemokine-binding protein

Read More

Clinical results for Zambon's N-acetylcysteine as chemopreventive agent

Read More

Lilly synthesizes antifolates that potently inhibit human DHFR

Read More

Sugen researchers discover co-crystal of FGF TK

Read More

In vivo and clinical antitumor activity of recombinant methioninase

Read More

MMP inhibitor from British Biotech effective against oxidant-induced lung injury

Read More

Tularik receives U.S. patent relating to enzyme associated with inflammation

Read More

Dual H1/NK1 antagonist for allergic rhinitis from HMR

Read More

In vivo growth arrest of mammary carcinoma by ibuprofen

Read More

Biota licenses compounds for the treatment of prostate cancer

Read More

SangStat Medical: Q1 1997 highlights

Read More

In vitro effects of combinations of tubulin-interacting agents and S-16020-2

Read More

BioChem Pharma subsidiary signs agreement to develop nasally delivered vaccines

Read More

Samjin characterizes novel antitumor agent

Read More

Promising results reported on new complex carbohydrate antifungal compound

Read More

LXR and Oxford Asymmetry enter drug discovery collaboration

Read More

AutoImmune reports preliminary results from phase II trials of Colloral

Read More

Ilex and LeukoSite form joint venture for development of Campath-1H

Read More

RPR and AMRAD initiate collaboration on antiasthmatic natural products

Read More

Roche seeks FDA approval for new formulation of saquinavir

Read More

Low-dose oral IFN-alpha + high-dose injectable IFN-alpha for hepatitis C

Read More

SmithKline Beecham and LG Chemical sign agreement for new antibiotic

Read More

CollaGenex promotes Ponstel for short-term dental pain relief

Read More

Centocor reports results from Crohn's disease studies

Read More

Popular Stories

  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • Silhouette of head, brain

    Plasticity, properly parsed, provides psychiatric platform

    BioWorld
    If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing